Certified by Founder Lodge
Elevara Medicines
United Kingdom - London Area
START UP
1 Disclosed Funding Rounds $70,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Starting a new era in rheumatoid arthritis treatment.
Elevara Medicines addresses a fundamental problem in rheumatoid arthritis (RA) where patients fail to achieve disease remission throug
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 24 ,2025 | Series A | $70,000,000 |
Monograph Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Furientis | $5,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Cosmico | $12,000,000 | (May 19, 2026)
